You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CAPITAL AND CODEINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Capital And Codeine patents expire, and what generic alternatives are available?

Capital And Codeine is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, and Carnrick. and is included in three NDAs.

The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Capital And Codeine

A generic version of CAPITAL AND CODEINE was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CAPITAL AND CODEINE?
  • What are the global sales for CAPITAL AND CODEINE?
  • What is Average Wholesale Price for CAPITAL AND CODEINE?
Summary for CAPITAL AND CODEINE
Drug patent expirations by year for CAPITAL AND CODEINE

US Patents and Regulatory Information for CAPITAL AND CODEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CAPITAL AND CODEINE acetaminophen; codeine phosphate SUSPENSION;ORAL 085883-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Valeant Pharms Llc CAPITAL AND CODEINE acetaminophen; codeine phosphate SUSPENSION;ORAL 086024-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Carnrick CAPITAL AND CODEINE acetaminophen; codeine phosphate TABLET;ORAL 083643-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.